NCT00576251: TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension |
|
|
| Completed | 3 | 221 | US | Tobramycin 0.3%/Dexamethasone 0.05%, TOBRADEX | Alcon Research | Ocular Inflammation Associated With Blepharaconjunctivitis | 02/08 | 03/08 | | |
NCT01028027: Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis |
|
|
| Completed | 3 | 357 | RoW | Loteprednol and tobramycin, Zylet, Tobramycin and dexamethasone, Tobradex | Bausch & Lomb Incorporated | Conjunctivitis, Keratitis, Blepharitis | 02/10 | 03/10 | | |
